Home > Journals > Minerva Cardiology and Angiology > Past Issues > Minerva Cardioangiologica 2004 December;52(6) > Minerva Cardioangiologica 2004 December;52(6):547-52

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Share

 

  HEART FAILURE 

Minerva Cardioangiologica 2004 December;52(6):547-52

Copyright © 2004 EDIZIONI MINERVA MEDICA

language: English

The clinical and electrophysiological implications of asymptomatic atrial fibrillation

Boodhoo L. E., Mitchell A. R. J., Sulke N.


PDF


Atrial fibrillation (AF) is the commonest arrhythmia encountered in clinical practice and is frequently associated with significant symptoms. Asymptomatic AF may also increase the risks of heart failure, thromboembolism and cardiomyopathy but its prevalence is significantly underestimated by routine surveillance methods. The development of long-term external monitors and implantable devices has offered a new insight into the true prevalence of asymptomatic AF. Similar management strategies should be applied to both symptomatic and asymptomatic patient groups and anticoagulation should be continued indefinitely in those with a history of AF and risk factors for thromboembolism. Enhanced detection of clinically silent AF could improve outcomes but the resource implications will be significant.

top of page